Transplantation of subretinal stem cell–derived retinal pigment epithelium for stargardt disease: A Phase I Clinical Trial
1. 系统已在2025-09-23 11:12:13对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
其他信息:
RAB Fernandes, FH Lojudice, LZ Ribeiro, NFS da Cruz…
Retina, 2023
journals.lww.com
Purpose: To assess the safety of injecting human embryonic stem cell retinal pigment epithelial cell dose to treat Stargardt disease. Methods: In this prospective, Phase I clinical trial, human embryonic stem cell retinal pigment epithelial cells in suspension were injected into the subretinal space in eyes with the worse best-corrected visual acuity (BCVA). After vitrectomy/posterior hyaloid removal, a partial retinal detachment was created and the human embryonic stem cell retinal pigment epithelial cells were administered …